Biotech4 years ago
ARTHEx receives €1.2 million from Cdti and can start the clinical trial
ARTHEx Biotech, specializing in finding new therapies for myotonic dystrophy, has just received a financing round of $1.36 million (€1.2 million) from the Center for the...